Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.4.2 has been added; the page content and purpose remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe update is a minor version bump from v3.4.0 to v3.4.1 with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision number updated to v3.3.2, replacing the previous v3.2.0.SummaryDifference0.1%

- Check100 days agoChange DetectedRemoved the banner warning about government funding potentially affecting up-to-date information and NIH Clinical Center operating status; no trial data or eligibility details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.